{"id":18300,"date":"2020-10-27T18:37:57","date_gmt":"2020-10-27T17:37:57","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=18300"},"modified":"2020-10-27T18:38:39","modified_gmt":"2020-10-27T17:38:39","slug":"proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/","title":{"rendered":"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">ProteoNic BV, a leading provider of technology and services in the field of production of biologics, announced it has licensed its premium 2G UNic\u2122 technology for boosting therapeutic protein production to Immunomedics, Inc. (NASDAQ:\u00a0<a href=\"https:\/\/www.prnewswire.com\/news-releases\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics-301155607.html?tc=eml_cleartime#financial-modal\">IMMU<\/a>), a biopharmaceutical company developing immuno-therapeutics for the treatment of cancer and other diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under the agreement, Immunomedics gains commercial rights for application of ProteoNic\u2019s technology platform to the development of specified proprietary products from mammalian cells. Financial details of the agreement were not disclosed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ProteoNic\u2019s protein expression technology improves production levels across a range of host cells, selection systems and protein targets. It increases transcription and translation rates via a combination of novel genetic elements, which together exert a powerful positive effect on recombinant protein production levels without impacting product quality or cell line stability attributes. 2G UNic\u2122 can be readily combined with other protein expression-enhancing technologies to improve their performance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mark Posno, Vice President of Business Development of ProteoNic commented: \u201cWe are pleased that we can contribute to improving the efficiency of production of Immunomedics\u2019 antibody-based products. ProteoNic\u2019s clients consistently achieve strongly increased cell line productivity and reduced manufacturing cost. We will continue our work towards reaching the maximum potential of the production of biologicals for current and future clients.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Source: ProteoNic (<a href=\"https:\/\/proteonic.nl\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/\">Press release<\/a>)<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ProteoNic BV, a leading provider of technology and services in the field of production of biologics, announced it has licensed its premium 2G UNic\u2122 technology for boosting therapeutic protein production to Immunomedics, Inc. (NASDAQ:\u00a0IMMU), a biopharmaceutical company developing immuno-therapeutics for the treatment of cancer and other diseases. Under the agreement, Immunomedics gains commercial rights for [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-18300","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics - hollandbio\" \/>\n<meta property=\"og:description\" content=\"ProteoNic BV, a leading provider of technology and services in the field of production of biologics, announced it has licensed its premium 2G UNic\u2122 technology for boosting therapeutic protein production to Immunomedics, Inc. (NASDAQ:\u00a0IMMU), a biopharmaceutical company developing immuno-therapeutics for the treatment of cancer and other diseases. Under the agreement, Immunomedics gains commercial rights for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-27T17:37:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-27T17:38:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics\",\"datePublished\":\"2020-10-27T17:37:57+00:00\",\"dateModified\":\"2020-10-27T17:38:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/\"},\"wordCount\":224,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/\",\"name\":\"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2020-10-27T17:37:57+00:00\",\"dateModified\":\"2020-10-27T17:38:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/","og_locale":"en_US","og_type":"article","og_title":"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics - hollandbio","og_description":"ProteoNic BV, a leading provider of technology and services in the field of production of biologics, announced it has licensed its premium 2G UNic\u2122 technology for boosting therapeutic protein production to Immunomedics, Inc. (NASDAQ:\u00a0IMMU), a biopharmaceutical company developing immuno-therapeutics for the treatment of cancer and other diseases. Under the agreement, Immunomedics gains commercial rights for [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/","og_site_name":"hollandbio","article_published_time":"2020-10-27T17:37:57+00:00","article_modified_time":"2020-10-27T17:38:39+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics","datePublished":"2020-10-27T17:37:57+00:00","dateModified":"2020-10-27T17:38:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/"},"wordCount":224,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/","name":"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2020-10-27T17:37:57+00:00","dateModified":"2020-10-27T17:38:39+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-immunomedics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=18300"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18300\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=18300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=18300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=18300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}